对常规白内障手术中前房内散瞳的评估
本研究在英国某中心比较前房内Mydrane(第2组,n=60)与术前局部散瞳剂(第1组,n=60)的白内障手术效果。两组术后视力相当,第2组术前等待时间更短、满意度更高,但手术室周转时间更长;作者认为Mydrane在多数患者中临床有效,但在该特定场景下未判定为常规使用具有成本效益的干预。
要点
- 第2组术后视力0.09±0.16与第1组0.08±0.15相当(p=0.59)。
- 第2组术前等待87分钟较第1组146分钟更短(p<0.0001),满意度76.0±11.2较66.3±8.6更高(p<0.0001)。
- 第2组手术室周转时间25分钟长于第1组22分钟。
核心结论
- 前房内散瞳在多数接受白内障手术的患者中临床有效,可能与患者体验改善和术前流程更顺畅相关。
- Mydrane是其他前房内散瞳剂超说明书使用的持证替代选择,但在该特定场景下未被判定为常规使用具有成本效益的干预。
研究设计与样本
- 作为使用前房内Mydrane的白内障手术局部评估的一部分(第2组;n=60),收集术中瞳孔大小、术后视力、机械性瞳孔扩张率、术中虹膜松弛综合征(IFIS)和并发症数据。
- 记录术前和手术室周转时间,患者术后完成经验证的满意度测量,并与既往接受现有标准术前局部散瞳剂方案的队列(第1组;n=60)比较。
主要发现
- 术后视力两组相当(第2组0.09±0.16 vs 第1组0.08±0.15;p=0.59)。
- 第2组瞳孔大小在撕囊前为7.0±1.0 mm,在皮质抽吸后为6.5±0.29 mm;在后一时间点,使用α受体拮抗剂的患者瞳孔更小(4.7±1.1 mm;p=0.004)。
- 第2组较第1组术前等待更短(87 vs 146分钟;p<0.0001),满意度更高(76.0±11.2 vs 66.3±8.6;p<0.0001),但手术室周转时间更长(25分钟 vs 22分钟)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracameral Mydrane might facilitate a more streamlined cataract service and improve the patient experience. There is limited 'real-world' evidence of its use in a UK setting. METHODS: As part of a local evaluation of cataract surgery using intracameral Mydrane (group 2; n=60), data were collected on intraoperative pupil size and postoperative visual acuity (VA), as well as the rate of mechanical pupil dilation, intraoperative floppy iris syndrome (IFIS) and complications. Preoperative and theatre turnaround time was recorded and patients completed a validated measure of satisfaction postoperatively. Data were compared with a previous cohort subjected to the existing standard regime of preoperative topical mydriatics (group 1; n=60). RESULTS: Postoperative VA was comparable between groups (0.09±0.16 vs 0.08±0.15; p=0.59). Pupil size in group 2 was 7.0±1.0 mm prior to capsulorhexis and 6.5±0.29 mm after cortical aspiration, with a smaller pupil in patients on alpha-antagonists (4.7±1.1 mm; p=0.004) at this later time point. Comparing group 2 with group 1, preoperative waiting was less (87 vs 146 min; p<0.0001) and satisfaction was higher (76.0±11.2 vs 66.3±8.6; p<0.0001), although theatre turnaround time was longer (25 min vs 22 min). CONCLUSION: Intracameral mydriasis was clinically effective in most patients undergoing cataract surgery and might be associated with an improved patient experience and a more streamlined preoperative flow. Mydrane represents a licensed alternative to the off-label use of other intracameral mydriatic agents, but was not judged to be a cost-effective intervention for routine use in this particular setting.
引用
- Schulz CB, Goverdhan SV, Humphry RC, et al. An evaluation of intracameral mydriasis for routine cataract surgery. Br J Ophthalmol. 2017. PMID: 28903962. doi:10.1136/bjophthalmol-2017-310510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。